Glypican-3 (GPC3) was reported to mediate the CSC properties like self-renewal, cell cycle progression, and tumor formation via autophagy induction in hepatocellular carcinoma, implicating it as a novel liver CSC marker (126). Here, GPC3 is linked to hepatocellular carcinoma.